RY 167.72 0.9449% SHOP 138.14 2.8363% TD 88.13 0.8237% ENB 64.29 -0.1863% BN 76.87 2.6439% TRI 253.97 -1.1982% CNQ 39.95 -0.125% CP 103.18 2.5035% CNR 138.0 4.2454% BMO 134.78 1.133% BNS 69.45 0.6522% CSU 5024.1851 0.7628% CM 88.0 0.7787% MFC 43.615 2.1429% ATD 71.18 2.1527% NGT 70.8 -0.6455% TRP 69.43 0.202% SU 49.85 0.8701% WCN 271.53 -0.0331% L 222.41 -0.6433%

small-cap

One NYSE - Listed Beverages Stock at Resistance Level: NAPA

Oct 08, 2024 | Team Kalkine
One NYSE - Listed Beverages Stock at Resistance Level: NAPA

NAPA:NYSE
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (US$)

The Duckhorn Portfolio, Inc

The Duckhorn Portfolio, Inc (NYSE: NAPA) is a luxury wine producer based in North America. It provides a carefully curated selection of premium wines, priced between USD 20 and USD 230, spanning over 15 varietals and 39 appellations. The portfolio includes renowned wineries such as Duckhorn Vineyards, Decoy, Sonoma-Cutrer, Kosta Browne, Goldeneye, Paraduxx, Calera, Migration, Postmark, Canvasback, and Greenwing.

As per our previous report published on ‘NAPA’ on 8th July 2024, Kalkine provided an Buystance on the stock at USD 6.87 based on fundamental analysis and the stock price has now moved by ~59.39% since then and is trading above resistance 2.

Noted below are the details of support and resistance levels provided in our previous report:

NAPA’s Daily Chart

Considering the target level attainments, declining revenue growth, reducing gross profits, and increasing volatility over global equity market an ‘Sell’ rating is assigned to the ‘NAPA’ at the closing market price of USD 10.95 as of Oct 07, 2024. 

Note: This report may be updated with details around fundamental and technical analysis, price chart in due course, as appropriate.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is Oct 07, 2024. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.


Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.